Eicosapentaenoic Acid as long-term secondary prevention after ischemic stroke

BACKGROUND: It is sometimes difficult to choose anti-thrombotic agents for secondary prevention in stroke patients at high bleeding risk. Recently, Eicosapentaenoic Acid (EPA) was reported to reduce the recurrence of stroke in hypercholesterolemic patients without increasing hemorrhagic risk. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakase, Taizen, Sasaki, Masahiro, Suzuki, Akifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471066/
https://www.ncbi.nlm.nih.gov/pubmed/26084813
http://dx.doi.org/10.1186/s40169-015-0062-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471066/
https://www.ncbi.nlm.nih.gov/pubmed/26084813
http://dx.doi.org/10.1186/s40169-015-0062-5

Ejemplares similares